echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > High-risk cancer early screening guidelines issued in China's cancer prevention and treatment level will take a new height

    High-risk cancer early screening guidelines issued in China's cancer prevention and treatment level will take a new height

    • Last Update: 2021-03-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 15, 2021, the Beijing Anti-Cancer Association's 2021 Early Cancer Screening Standardization Seminar and The China High Risk Cancer Early Screening Guidelines press conference were held online.
    Beijing Anti-Cancer Association was founded by well-known experts and professors in the field of oncology in Beijing, and has been promoting the concept of early screening for cancer in recent years.
    In response to the goal of increasing screening rates for key cancer species in high-risk areas in the Health China Initiative (2019-2030), the Beijing Anti-Cancer Association's Professional Committee on Early Cancer Screening has launched early cancer screening guidelines for high-risk cancers, which are dedicated to promoting and regulating early cancer screening in China.
    Beijing Anti-Cancer Association Early Cancer Screening Professional Committee Chairman, Peking University Cancer Hospital Urology Director Professor Du Peng announced at the press conference: "In the early cancer screening professional committee of the group leaders, members and experts of the joint efforts of lung tumors, gastrointestinal tumors, esophageal tumors, urological tumors, liver and bile tumors, gynecological tumors and other types of early cancer screening finally have authoritative guidelines, China's cancer prevention and treatment level will reach a new height!" "Early cancer screening needs to be standardized.
    , chairman of the Beijing Cancer Society and president of Peking University Cancer Hospital, stressed at the meeting: "Early cancer screening requires scientific guidance and strict management.
    ", it is understood that for the early screening of malignant tumors, China has been lacking comprehensive, authoritative guidelines and consensus.
    It is against this background that the preparation of the Beijing Cancer Association's top ten cancer screening guidelines has been successfully completed, and the first "Beijing Anti-Cancer Association - Early Cancer Screening Base" has landed at Beijing Jingxi Cancer Hospital.
    " to further implement the Healthy China strategy and formulate early cancer screening norms and consensus in line with China's national conditions is our duty and responsibility.
    years, the Beijing Anti-Cancer Association has set up its own early cancer screening base, trained a professional early cancer screening team, and achieved good social response.
    ," Professor Du Peng said.
    healthy China Initiative (2019-2030), the five-year survival rate for cancer will increase to 43.3% and 46.6%, respectively, by 2022 and 2030.
    Professor Zhu Jun, Party Secretary of Peking University Cancer Hospital and Director of Lymphoma Internal Medicine, said at the press conference that the overall survival rate of Peking University Cancer Hospital has reached or exceeded this basic goal in the past ten years, but from a national perspective, there is still a long way to go to achieve this goal.
    needs the attention of the whole society.
    is not only the popularization of public health education expertise, but also, more importantly, to improve the overall level of diagnosis and treatment of oncology specialist medical personnel.
    Shen Lin, Vice Dean of Oncology Hospital of Peking University and Director of Digestive Oncology, first gave full recognition to the publication of the China Early Screening Guidelines for High-Risk Cancer at the press conference.
    , Professor Shen also shared a keynote report entitled "The Current and Future of Early Gastrointestinal Cancer Screening".
    Shen Lin said: "The incidence and mortality rate of colorectal cancer have increased significantly worldwide, and both stomach cancer and colorectal cancer are high-risk cancers in China.
    there is still a gap between the five-year survival rate of stomach cancer and colorectal cancer in China compared with that of developed countries abroad.
    is that the early diagnosis rate of stomach cancer and colorectal cancer in China is much lower than in developed countries.
    currently targeted at colorectal cancer, in addition to routine endoscopy, there are new screening methods, through the detection of biomarkers in human feces, early and accurate detection of intestinal lesions.
    this new fecal multi-target FIT-DNA test has obtained the first and currently the only early cancer screening license in China and can be used for screening of people at high risk of colorectal cancer.
    hope that all cancer species can find easy screening methods suitable for China's national conditions, and establish a system of early diagnosis and treatment of cancer.
    conference, experts from the Beijing Anti-Cancer Association's Professional Committee on Early Cancer Screening introduced and interpreted the screening guidelines for each cancer species in the China High Incidence Cancer Early Screening Guidelines.
    To further advance cancer screening and prevention efforts, the Association has also introduced an integrated screening for early cancer covering high-risk cancers, tailored screening programs to individual cancer risk, and targeted assessment and interpretation, in line with the focus of the guidelines.
    it is understood that the service will be officially launched in Beijing Jingxi Cancer Hospital early cancer screening base, the future will also be in Beijing a number of public hospitals and medical examination centers to promote.
    In the future, The Beijing Anti-Cancer Association will continue to participate in the promotion of early diagnosis and treatment of cancer, strengthen the empowerment and standardized management of early cancer screening base, pay attention to the training of anti-cancer screening professionals, while actively promoting anti-cancer popular science publicity, advocating the public to take the initiative to participate in early cancer screening, promote the development of cancer screening and early diagnosis and treatment work!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.